Skip to main content

Table 2 Correlation analysis between leukocyte apoptosis markers and disease activity and steroid dosage in patients with systemic lupus erythematosus

From: Investigation of the caspase-dependent mitochondrial apoptotic pathway in mononuclear cells of patients with systemic lupus erythematosus

  SLE diseases activity Steroid dosage
  r p r p
CD4+ cell Annexin V (%) 0.02 0.93 0.01 0.96
CD4+ cell Annexin V + 7AAD (%) -0.09 0.70 -0.33 0.12
CD8+ cell Annexin V (%) -0.30 0.19 -0.17 0.45
CD8+ cell Annexin V + 7AAD (%) -0.06 0.79 -0.19 0.39
CD19+ cell Annexin V (%) 0.17 0.46 -0.19 0.39
CD19+ cell Annexin V + 7AAD (%) 0.12 0.61 -0.15 0.50
Monocyte Annexin V (%) 0.01 0.97 -0.11 0.54
Monocyte Annexin V + 7AAD (%) 0.04 0.85 -0.14 0.46
APO2.7 CD4+ cell (%) 0.17 0.51 -0.29 0.20
APO2.7 CD8+ cell (%) 0.32 0.19 -0.12 0.61
APO2.7 CD19+ cell (%) 0.59 0.01* 0.17 0.46
APO2.7 monocyte (%) 0.05 0.77 -0.17 0.35
  1. Abbreviations: r, correlation coefficient; p, p value; SLEDAI, Systemic lupus erythematosus disease activity index 2000.
  2. *p < 0.05.